Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 66993-370

10 FDA label images from Prasco Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 66993-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Medroxyprogesterone 01)

Figure 1 (Medroxyprogesterone 01)
A logarithmic scale chart displaying odds ratios with 95% confidence intervals for various studies evaluating DMPA (medroxyprogesterone acetate) use. The x-axis shows odds ratio values, and the y-axis lists different studies with corresponding odds ratios and confidence intervals, indicating risk levels associated with DMPA use over different time periods and subject groups.*
FDA Label Image

Chemical Structure (Medroxyprogesterone 02)

Chemical Structure (Medroxyprogesterone 02)
Chemical structure of medroxyprogesterone acetate showing its steroidal backbone with characteristic rings and functional groups.*
FDA Label Image

Logo (Medroxyprogesterone 03)

FDA Label Image

Image (Medroxyprogesterone 04)

Image (Medroxyprogesterone 04)
A vertical arrow diagram illustrating pregnancy rates per 100 women in one year, ranging from fewer than 1 to 85 or more pregnancies. It categorizes contraceptive methods by effectiveness: implants, injections, intrauterine devices, and sterilization at the highest effectiveness; birth control pills, skin patch, and vaginal ring with hormones slightly less so; condoms and diaphragm less effective; no sex during fertile days, spermicide, and withdrawal next; and no birth control with the highest pregnancy rate.*
FDA Label Image

Logo (Medroxyprogesterone 05)

FDA Label Image

Principal Display Panel (150 mg/mL Vial Label)

Principal Display Panel (150 mg/mL Vial Label)
Label for medroxyprogesterone acetate 150 mg/mL injection, suspension, for intramuscular use. The label indicates it is a single-dose vial, distributed by Prasco Laboratories, Mason, OH. Directions include shaking vigorously before use and storing upright. The NDC number 66993-370-83 is shown along with a lot/expiration area.*
FDA Label Image

Principal Display Panel (150 mg/mL Vial Carton)

Principal Display Panel (150 mg/mL Vial Carton)
Packaging label for medroxyprogesterone acetate 150 mg/mL injection, suspension, USP by Prasco Laboratories. The label states it is for intramuscular use only and is available as a 1 mL single-dose vial. It includes storage instructions, dosage and use directions, and the NDC number 66993-370-83. The label features the Prasco logo and a barcode.*
FDA Label Image

Principal Display Panel (150 mg/mL Vial Carton)

Principal Display Panel (150 mg/mL Vial Carton)
Box packaging label for MedroxyPROGESTERone Acetate Injectable Suspension, USP 150 mg/mL by Prasco Laboratories. The label indicates it is for intramuscular use only and prescription use. The box contains 25 single-dose 1 mL vials. Storage instructions and a list of inactive ingredients are also included on the label.*
FDA Label Image

Principal Display Panel (150 mg/mL Syringe Label)

Principal Display Panel (150 mg/mL Syringe Label)
Label of Medroxyprogesterone Acetate injectable suspension, USP, 150 mg/mL, for intramuscular use. It is a 1 mL single-use syringe labeled Rx only, distributed by Prasco Laboratories, Mason, OH. The label includes instructions to shake vigorously before use and has barcode information along with a placeholder for lot and expiration details.*
FDA Label Image

Principal Display Panel (150 mg/mL Syringe Carton)

Principal Display Panel (150 mg/mL Syringe Carton)
Packaging label for Medroxyprogesterone Acetate Injectable Suspension USP 150 mg/mL, a single use 1 mL prefilled syringe for intramuscular use. The label includes directions for syringe preparation, needle activation, storage instructions at controlled room temperature, and is distributed by Prasco Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.